The FDA has granted approval for the ANDA of Lupin’s Sacubitril and Valsartan Tablets for heart failure patients.
Aim In the clinical setting of acute myocarditis, existing guidelines recommend refraining from moderate-intensity to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback